MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,566 | +48.3% | 127,774 | +23.0% | 0.00% | +50.0% |
| Q2 2023 | $3,752 | -28.9% | 103,871 | -26.8% | 0.00% | 0.0% |
| Q1 2023 | $5,275 | -49.0% | 141,860 | -37.9% | 0.00% | -60.0% |
| Q4 2022 | $10,351 | -99.9% | 228,425 | +79.7% | 0.01% | -50.0% |
| Q3 2022 | $8,875,000 | +1009.4% | 127,094 | +966.9% | 0.01% | – |
| Q2 2022 | $800,000 | -59.8% | 11,913 | -50.7% | 0.00% | -100.0% |
| Q1 2022 | $1,989,000 | -79.1% | 24,176 | -62.8% | 0.00% | 0.0% |
| Q4 2021 | $9,524,000 | +148.1% | 64,940 | +199.3% | 0.00% | +100.0% |
| Q3 2021 | $3,839,000 | -21.0% | 21,696 | -27.9% | 0.00% | -50.0% |
| Q2 2021 | $4,860,000 | -27.7% | 30,090 | -23.4% | 0.00% | -50.0% |
| Q1 2021 | $6,726,000 | -20.5% | 39,265 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $8,463,000 | -45.5% | 38,529 | -58.8% | 0.00% | -55.6% |
| Q3 2020 | $15,521,000 | +54.1% | 93,467 | +6.0% | 0.01% | +12.5% |
| Q2 2020 | $10,070,000 | +22.9% | 88,195 | -17.2% | 0.01% | +33.3% |
| Q1 2020 | $8,191,000 | +9.3% | 106,565 | +83.2% | 0.01% | +50.0% |
| Q4 2019 | $7,497,000 | +45.0% | 58,171 | -12.4% | 0.00% | +33.3% |
| Q3 2019 | $5,171,000 | -14.8% | 66,372 | +12.7% | 0.00% | -25.0% |
| Q2 2019 | $6,066,000 | -73.7% | 58,897 | -81.3% | 0.00% | -76.5% |
| Q1 2019 | $23,078,000 | +1266.4% | 314,830 | +691.0% | 0.02% | +1600.0% |
| Q4 2018 | $1,689,000 | -87.9% | 39,803 | -86.5% | 0.00% | -90.0% |
| Q3 2018 | $13,918,000 | +260.8% | 295,503 | +277.6% | 0.01% | +233.3% |
| Q2 2018 | $3,858,000 | +212.9% | 78,251 | +94.7% | 0.00% | +200.0% |
| Q1 2018 | $1,233,000 | +275.9% | 40,200 | +123.3% | 0.00% | – |
| Q4 2017 | $328,000 | +124.7% | 18,000 | +44.0% | 0.00% | – |
| Q3 2017 | $146,000 | +22.7% | 12,500 | -61.6% | 0.00% | – |
| Q2 2017 | $119,000 | +260.6% | 32,586 | +410.6% | 0.00% | – |
| Q1 2017 | $33,000 | +1550.0% | 6,382 | +1122.6% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 522 | +81.2% | 0.00% | – |
| Q3 2016 | $2,000 | -90.5% | 288 | -92.6% | 0.00% | – |
| Q2 2016 | $21,000 | +31.2% | 3,895 | +409.8% | 0.00% | – |
| Q1 2016 | $16,000 | +433.3% | 764 | +641.7% | 0.00% | – |
| Q4 2015 | $3,000 | -50.0% | 103 | -45.8% | 0.00% | – |
| Q2 2015 | $6,000 | -14.3% | 190 | -27.2% | 0.00% | – |
| Q1 2015 | $7,000 | -30.0% | 261 | -55.2% | 0.00% | – |
| Q4 2014 | $10,000 | +150.0% | 583 | +147.0% | 0.00% | – |
| Q3 2014 | $4,000 | +33.3% | 236 | +50.3% | 0.00% | – |
| Q2 2014 | $3,000 | -82.4% | 157 | -82.3% | 0.00% | – |
| Q1 2014 | $17,000 | – | 887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |